nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—NR3C1—urine—schizophrenia	0.0387	0.132	CbGeAlD
Cyproterone acetate—Ethynodiol—ESR1—schizophrenia	0.0209	0.576	CrCbGaD
Cyproterone acetate—NR3C1—blood plasma—schizophrenia	0.0202	0.0691	CbGeAlD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—schizophrenia	0.02	0.0298	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—NR4A2—schizophrenia	0.0193	0.0288	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—PAWR—schizophrenia	0.0175	0.026	CbGpPWpGaD
Cyproterone acetate—CYP19A1—forebrain—schizophrenia	0.0173	0.0591	CbGeAlD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NOS1AP—schizophrenia	0.0169	0.0251	CbGpPWpGaD
Cyproterone acetate—AR—forebrain—schizophrenia	0.0153	0.0523	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR4A2—schizophrenia	0.0153	0.0227	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—NR4A2—schizophrenia	0.0147	0.0218	CbGpPWpGaD
Cyproterone acetate—AR—telencephalon—schizophrenia	0.014	0.0481	CbGeAlD
Cyproterone acetate—CYP19A1—gonad—schizophrenia	0.0132	0.0453	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NOS1AP—schizophrenia	0.0128	0.019	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—SMARCA2—schizophrenia	0.0126	0.0187	CbGpPWpGaD
Cyproterone acetate—AR—gonad—schizophrenia	0.0117	0.0401	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—NR4A2—schizophrenia	0.0116	0.0172	CbGpPWpGaD
Cyproterone acetate—CYP19A1—blood—schizophrenia	0.0115	0.0395	CbGeAlD
Cyproterone acetate—NR3C1—forebrain—schizophrenia	0.0111	0.0379	CbGeAlD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—TPH1—schizophrenia	0.0108	0.0161	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—TLE1—schizophrenia	0.0107	0.016	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—schizophrenia	0.0103	0.0153	CbGpPWpGaD
Cyproterone acetate—AR—blood—schizophrenia	0.0102	0.035	CbGeAlD
Cyproterone acetate—NR3C1—telencephalon—schizophrenia	0.0102	0.0348	CbGeAlD
Cyproterone acetate—CYP19A1—endocrine gland—schizophrenia	0.01	0.0343	CbGeAlD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.0098	0.0146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.00968	0.0144	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SMARCA2—schizophrenia	0.00955	0.0142	CbGpPWpGaD
Cyproterone acetate—CYP19A1—nervous system—schizophrenia	0.00937	0.0321	CbGeAlD
Cyproterone acetate—CYP19A1—central nervous system—schizophrenia	0.00902	0.0309	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—schizophrenia	0.00888	0.245	CrCbGaD
Cyproterone acetate—AR—endocrine gland—schizophrenia	0.00886	0.0303	CbGeAlD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CLOCK—schizophrenia	0.00882	0.0131	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PAK6—schizophrenia	0.00871	0.013	CbGpPWpGaD
Cyproterone acetate—NR3C1—gonad—schizophrenia	0.00849	0.0291	CbGeAlD
Cyproterone acetate—AR—nervous system—schizophrenia	0.00829	0.0284	CbGeAlD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—TCF4—schizophrenia	0.00801	0.0119	CbGpPWpGaD
Cyproterone acetate—AR—central nervous system—schizophrenia	0.00798	0.0273	CbGeAlD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.00795	0.0118	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—NTS—schizophrenia	0.00764	0.0114	CbGpPWpGaD
Cyproterone acetate—NR3C1—blood—schizophrenia	0.0074	0.0253	CbGeAlD
Cyproterone acetate—NR3C1—midbrain—schizophrenia	0.00731	0.025	CbGeAlD
Cyproterone acetate—CYP19A1—FSH signaling pathway—BDNF—schizophrenia	0.00728	0.0108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—brain—schizophrenia	0.00716	0.0245	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TLE1—schizophrenia	0.00702	0.0104	CbGpPWpGaD
Cyproterone acetate—Megestrol acetate—ABCB1—schizophrenia	0.00647	0.179	CrCbGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—schizophrenia	0.00645	0.0096	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—CLOCK—schizophrenia	0.00642	0.00956	CbGpPWpGaD
Cyproterone acetate—NR3C1—endocrine gland—schizophrenia	0.00642	0.022	CbGeAlD
Cyproterone acetate—AR—brain—schizophrenia	0.00634	0.0217	CbGeAlD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.00624	0.00929	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—NDST3—schizophrenia	0.00608	0.00905	CbGpPWpGaD
Cyproterone acetate—NR3C1—nervous system—schizophrenia	0.00601	0.0206	CbGeAlD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1A2—schizophrenia	0.00592	0.00882	CbGpPWpGaD
Cyproterone acetate—NR3C1—central nervous system—schizophrenia	0.00578	0.0198	CbGeAlD
Cyproterone acetate—NR3C1—cerebellum—schizophrenia	0.00565	0.0194	CbGeAlD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.00529	0.00788	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.00523	0.00778	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—FOS—schizophrenia	0.00512	0.00762	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—ESR1—schizophrenia	0.00483	0.00719	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.00479	0.00713	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.00477	0.0071	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.00473	0.00705	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.00473	0.00704	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.00473	0.00704	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.00473	0.00703	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CYP26B1—schizophrenia	0.00466	0.00693	CbGpPWpGaD
Cyproterone acetate—NR3C1—brain—schizophrenia	0.00459	0.0157	CbGeAlD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—schizophrenia	0.00454	0.00675	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—ESR1—schizophrenia	0.00429	0.00639	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.00429	0.00639	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP26B1—schizophrenia	0.00422	0.00629	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP26B1—schizophrenia	0.00416	0.0062	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.00393	0.00586	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00388	0.00578	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—FOS—schizophrenia	0.00387	0.00576	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR1—schizophrenia	0.00382	0.00568	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GCLM—schizophrenia	0.00376	0.0056	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00371	0.00552	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TH—schizophrenia	0.00368	0.00548	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR1—schizophrenia	0.00366	0.00545	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—schizophrenia	0.00366	0.00545	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.00362	0.00539	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.00359	0.00534	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.00359	0.00534	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.00358	0.00534	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00339	0.00505	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—MEF2C—schizophrenia	0.00337	0.00502	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—schizophrenia	0.00337	0.00502	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—GSK3B—schizophrenia	0.00336	0.005	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.00335	0.00499	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.00326	0.00486	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.00323	0.00481	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—schizophrenia	0.00319	0.00474	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00308	0.00459	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—PRL—schizophrenia	0.00301	0.00448	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.00299	0.00444	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00297	0.00442	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—schizophrenia	0.00289	0.00431	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.00286	0.00427	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.00286	0.00427	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—schizophrenia	0.00286	0.00426	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00282	0.00419	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00279	0.00415	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—schizophrenia	0.00275	0.00409	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.00272	0.00405	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR4A2—schizophrenia	0.00264	0.00392	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—schizophrenia	0.00264	0.00392	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00257	0.00383	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—EP300—schizophrenia	0.00256	0.00382	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TH—schizophrenia	0.00255	0.0038	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—GSK3B—schizophrenia	0.00255	0.00379	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.00255	0.00379	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.00248	0.00369	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—EP300—schizophrenia	0.00243	0.00362	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.00237	0.00354	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00234	0.00348	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2D6—schizophrenia	0.00228	0.00339	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00225	0.00335	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2D6—schizophrenia	0.00225	0.00335	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ESR1—schizophrenia	0.00225	0.00334	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.00224	0.00334	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.00224	0.00334	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—schizophrenia	0.00223	0.00333	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—GSK3B—schizophrenia	0.00222	0.0033	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TSNAX—schizophrenia	0.00221	0.00329	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—EP300—schizophrenia	0.00221	0.00329	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.00217	0.00324	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.00217	0.00324	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.00216	0.00321	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00211	0.00315	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.00208	0.0031	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A2—schizophrenia	0.00206	0.00307	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—schizophrenia	0.00205	0.00305	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A2—schizophrenia	0.00203	0.00303	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—FOS—schizophrenia	0.00202	0.00301	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR4A2—schizophrenia	0.002	0.00298	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—schizophrenia	0.002	0.00298	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00199	0.00296	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—schizophrenia	0.00197	0.00293	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TH—schizophrenia	0.00194	0.00288	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.00193	0.00288	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.00187	0.00278	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.0018	0.00268	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—LSM1—schizophrenia	0.0018	0.00268	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—schizophrenia	0.0018	0.00267	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.00179	0.00267	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—FOS—schizophrenia	0.00178	0.00266	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.00177	0.00263	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.00176	0.00262	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.00174	0.00259	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—COMT—schizophrenia	0.00173	0.00257	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTP1—schizophrenia	0.00172	0.00256	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—MAOA—schizophrenia	0.00172	0.00255	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—COMT—schizophrenia	0.0017	0.00254	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTP1—schizophrenia	0.0017	0.00253	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—MEF2C—schizophrenia	0.0017	0.00252	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.00169	0.00251	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TSNAX—schizophrenia	0.00168	0.0025	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—EP300—schizophrenia	0.00168	0.00249	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.00164	0.00243	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—EP300—schizophrenia	0.00163	0.00242	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.0016	0.00238	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—schizophrenia	0.00159	0.00237	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—schizophrenia	0.00158	0.00235	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.00158	0.00235	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.00157	0.00234	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—schizophrenia	0.00156	0.00232	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00151	0.00224	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PRODH—schizophrenia	0.00148	0.0022	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.00147	0.00218	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EP300—schizophrenia	0.00146	0.00217	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.00142	0.00211	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.00138	0.00205	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—LSM1—schizophrenia	0.00137	0.00203	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.00136	0.00202	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH4—schizophrenia	0.00135	0.00201	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EP300—schizophrenia	0.00134	0.002	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.00133	0.00198	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.00133	0.00198	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR4A2—schizophrenia	0.00127	0.00189	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MPC2—schizophrenia	0.00121	0.00179	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.00119	0.00178	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—schizophrenia	0.00119	0.00178	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—schizophrenia	0.00118	0.00176	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—schizophrenia	0.00118	0.00175	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SMG6—schizophrenia	0.00116	0.00173	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.00112	0.00167	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLCH2—schizophrenia	0.00112	0.00167	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NDST3—schizophrenia	0.00105	0.00157	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.00104	0.00155	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH4—schizophrenia	0.00102	0.00152	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACSL6—schizophrenia	0.000999	0.00149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC27A5—schizophrenia	0.000999	0.00149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000976	0.00145	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR4A2—schizophrenia	0.000963	0.00143	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—schizophrenia	0.00096	0.00143	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.000956	0.00142	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DAO—schizophrenia	0.000953	0.00142	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	0.000951	0.00142	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—schizophrenia	0.000931	0.00139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PNP—schizophrenia	0.000913	0.00136	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—schizophrenia	0.000882	0.00131	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SMG6—schizophrenia	0.000881	0.00131	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NDUFV2—schizophrenia	0.000849	0.00126	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—schizophrenia	0.000846	0.00126	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.000822	0.00122	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIP4K2A—schizophrenia	0.000798	0.00119	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.000792	0.00118	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000792	0.00118	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.00079	0.00118	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—schizophrenia	0.000756	0.00113	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP26B1—schizophrenia	0.000722	0.00107	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	0.000721	0.00107	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—schizophrenia	0.000714	0.00106	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—schizophrenia	0.000706	0.00105	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.000684	0.00102	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—schizophrenia	0.000663	0.000988	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—schizophrenia	0.000659	0.000981	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH4—schizophrenia	0.00065	0.000967	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TPH1—schizophrenia	0.000644	0.000958	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCLM—schizophrenia	0.000644	0.000958	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.000643	0.000957	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000607	0.000903	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PRKD1—schizophrenia	0.000605	0.000901	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.000588	0.000876	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT1—schizophrenia	0.000583	0.000868	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000578	0.00086	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPA8—schizophrenia	0.000575	0.000855	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—schizophrenia	0.000573	0.000854	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	0.000567	0.000844	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPA1A—schizophrenia	0.000523	0.000779	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GAPDH—schizophrenia	0.000505	0.000752	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CLOCK—schizophrenia	0.0005	0.000745	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—schizophrenia	0.0005	0.000744	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000499	0.000743	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000497	0.00074	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000494	0.000735	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH4—schizophrenia	0.000493	0.000734	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TPH2—schizophrenia	0.000488	0.000726	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CACNB2—schizophrenia	0.000488	0.000726	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DPYD—schizophrenia	0.00048	0.000714	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.000479	0.000712	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CACNA1C—schizophrenia	0.000446	0.000664	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—DNMT1—schizophrenia	0.000442	0.000658	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPA8—schizophrenia	0.000436	0.000649	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3C2A—schizophrenia	0.000435	0.000647	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPA1A—schizophrenia	0.000397	0.000591	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2D6—schizophrenia	0.00039	0.00058	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SNAP25—schizophrenia	0.00039	0.00058	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—YWHAZ—schizophrenia	0.00038	0.000565	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A2—schizophrenia	0.000353	0.000525	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TH—schizophrenia	0.000348	0.000517	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—schizophrenia	0.000317	0.000472	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COMT—schizophrenia	0.000295	0.00044	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—schizophrenia	0.000294	0.000438	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MAOA—schizophrenia	0.000293	0.000437	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—YWHAZ—schizophrenia	0.000288	0.000429	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000285	0.000424	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—schizophrenia	0.000278	0.000414	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—schizophrenia	0.00027	0.000402	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLA2G4A—schizophrenia	0.00027	0.000402	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—schizophrenia	0.000241	0.000358	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—schizophrenia	0.000239	0.000356	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—schizophrenia	0.000222	0.000331	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA1—schizophrenia	0.00022	0.000327	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—schizophrenia	0.000127	0.000189	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—schizophrenia	0.000114	0.00017	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—schizophrenia	8.68e-05	0.000129	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—schizophrenia	7.66e-05	0.000114	CbGpPWpGaD
